Emcure Pharma Postal Ballot: Muralidharan Independent Director Appointment

Emcure Pharmaceuticals issued a Postal Ballot Notice dated March 24, 2026, under Regulation 30 of SEBI LODR, to appoint Mr. C S Muralidharan as Independent Director.
Mr. Muralidharan (DIN: 00014740), ex-Group CFO of Sun Pharma, is proposed for a 3-year term effective April 01, 2026, via Special Resolution.
Remote e-voting window runs from March 26, 2026 (9:00 a.m. IST) to April 24, 2026 (5:00 p.m. IST), with results to be declared by April 28, 2026.
The Board approved the appointment at its meeting on March 09, 2026, on recommendation of the Nomination and Remuneration Committee.